TVTX
UNKNOWNTravere Therapeutics, Inc.
CIK: 0001438533
Last activity: 2 weeks ago
Financial Metrics
As of Dec 31, 2025 (10-K)
Insider Roster (7 total, 7 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
|
0 | 5 | -$6.84M |
432,886 shares
$13.03M
|
|
ROTE WILLIAM E.
Chief Research Officer
|
0 | 2 | -$2.82M |
109,087 shares
$3.59M
|
|
REED ELIZABETH E
Chief Legal Officer and GC
|
0 | 7 | -$1.16M |
105,211 shares
$2.95M
|
|
Inrig Jula
CHIEF MEDICAL OFFICER
|
0 | 6 | -$1.01M |
105,938 shares
$3.40M
|
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
|
0 | 3 | -$540K |
49,080 shares
$1.58M
|
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
|
0 | 2 | -$434K |
131,823 shares
$4.23M
|
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
|
0 | 3 | -$289K |
111,336 shares
$3.58M
|
Recent Transactions
10,000 shares @ $28.09
$281K
Mar 16, 2026
60,000 shares @ $30.10
$1.81M
Feb 20, 2026
5,679 shares @ $27.50
$156K
Feb 17, 2026
4,321 shares @ $28.26
$122K
Feb 17, 2026
2,485 shares @ $32.07
$80K
Feb 4, 2026
1,635 shares @ $32.14
$53K
Feb 4, 2026
1,547 shares @ $32.11
$50K
Feb 4, 2026
509 shares @ $32.74
$17K
Feb 4, 2026
232 shares @ $32.85
$8K
Feb 4, 2026
110 shares @ $32.90
$4K
Feb 4, 2026
66,452 shares @ $32.06
$2.13M
Feb 3, 2026
33,635 shares @ $32.70
$1.10M
Feb 3, 2026
12,446 shares @ $32.87
$409K
Feb 3, 2026
7,310 shares @ $32.12
$235K
Feb 3, 2026
7,242 shares @ $32.12
$233K
Feb 3, 2026
7,175 shares @ $32.12
$230K
Feb 3, 2026
6,956 shares @ $32.12
$223K
Feb 3, 2026
4,333 shares @ $32.12
$139K
Feb 3, 2026
51,865 shares @ $30.10
$1.56M
Jan 27, 2026
8,135 shares @ $30.01
$244K
Jan 23, 2026
10,000 shares @ $27.34
$273K
Jan 20, 2026
445 shares @ $37.75
$17K
Jan 6, 2026
2,031 shares @ $40.18
$82K
Jan 5, 2026
60,000 shares @ $40.10
$2.41M
Dec 24, 2025
15,000 shares @ $42.00
$630K
Dec 24, 2025
7,402 shares @ $40.00
$296K
Dec 24, 2025
4,980 shares @ $40.00
$199K
Dec 24, 2025
2,910 shares @ $36.00
$105K
Dec 15, 2025
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.